{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:31Z","timestamp":1772166211124,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI14\/01693"],"award-info":[{"award-number":["PI14\/01693"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI16\/00684"],"award-info":[{"award-number":["PI16\/00684"]}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CTS2593"],"award-info":[{"award-number":["CTS2593"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish AIDS Research Network of Excellence","award":["RD16\/0025\/0019"],"award-info":[{"award-number":["RD16\/0025\/0019"]}]},{"name":"ViiV Healthcare S.L.","award":["205644"],"award-info":[{"award-number":["205644"]}]},{"name":"Instituto de Salud Carlos III (ES)","award":["FI00\/00431"],"award-info":[{"award-number":["FI00\/00431"]}]},{"name":"Consejer\u00eda de Salud y Bienestar Social of Junta de Andaluc\u00eda","award":["C-0013-2017"],"award-info":[{"award-number":["C-0013-2017"]}]},{"name":"Consejer\u00eda de Salud y Bienestar Social of Junta de Andaluc\u00eda","award":["C-0032-2017"],"award-info":[{"award-number":["C-0032-2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1617-1","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:50:49Z","timestamp":1535557849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination"],"prefix":"10.1186","volume":"16","author":[{"given":"In\u00e9s","family":"Herrero-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Rosado-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Genebat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Taranc\u00f3n-D\u00edez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Mar","family":"Rodr\u00edguez-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Mar","family":"Pozo-Balado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-8083","authenticated-orcid":false,"given":"Yolanda M.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"issue":"5 suppl","key":"1617_CR1","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1002\/hep.22883","volume":"49","author":"CL Thio","year":"2009","unstructured":"Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(5 suppl):S138\u201345.","journal-title":"Hepatology"},{"issue":"16","key":"1617_CR2","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1097\/QAD.0b013e32831103ad","volume":"22","author":"GM Clifford","year":"2008","unstructured":"Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, et al. Influence\u00a0of\u00a0HIV-related\u00a0immunodeficiency\u00a0on the\u00a0risk of\u00a0hepatocellular carcinoma. AIDS. 2008;22(16):2135\u201341.","journal-title":"AIDS"},{"key":"1617_CR3","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1473-3099(12)70243-8","volume":"12","author":"JA Whitaker","year":"2012","unstructured":"Whitaker JA, Rouphael NG, Edupuganti S, Lai L, Mulligan MJ. Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect Dis. 2012;12:966\u201376.","journal-title":"Lancet Infect Dis."},{"key":"1617_CR4","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.2119\/molmed.2012.00206","volume":"18","author":"SJ Westrop","year":"2012","unstructured":"Westrop SJ, Moyle G, Jackson A, Nelson M, Mandalia S, Imami N. CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection. Mol Med. 2012;18:1240\u20138.","journal-title":"Mol Med"},{"issue":"1","key":"1617_CR5","doi-asserted-by":"publisher","first-page":"e02050","DOI":"10.1128\/AAC.02050-17","volume":"62","author":"I Herrero-Fern\u00e1ndez","year":"2017","unstructured":"Herrero-Fern\u00e1ndez I, Pacheco YM, Genebat M, Rodriguez-M\u00e9ndez MDM, Lozano MDC, Polaino MJ, et al. Association between a suppressive combined antiretroviral therapy containing maraviroc and the hepatitis B virus vaccine response. Antimicrob Agents Chemother. 2017;62(1):e02050\u2013117.","journal-title":"Antimicrob Agents Chemother"},{"key":"1617_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2014.08.011","volume":"111","author":"MC Romero-S\u00e1nchez","year":"2014","unstructured":"Romero-S\u00e1nchez MC, Alvarez-R\u00edos AI, Bernal-Morell E, Genebat M, Vera F, Benhnia MR, et al. Maintenance of virologic efficacy and decrease in levels of \u03b22-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy. Antiviral Res. 2014;111:26\u201332.","journal-title":"Antiviral Res"},{"issue":"10","key":"1617_CR7","doi-asserted-by":"publisher","first-page":"e13188","DOI":"10.1371\/journal.pone.0013188","volume":"5","author":"N Funderburg","year":"2010","unstructured":"Funderburg N, Kalinowska M, Eason J, Goodrich J, Heera J, Mayer H, et al. Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients. PLoS ONE. 2010;5(10):e13188.","journal-title":"PLoS ONE"},{"key":"1617_CR8","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/AAC.01406-12","volume":"56","author":"MC Romero-S\u00e1nchez","year":"2012","unstructured":"Romero-S\u00e1nchez MC, Machmach K, Gonzalez-Serna A, Genebat M, Pulido I, Garc\u00eda-Garc\u00eda M, et al. Effect of maraviroc on HIV disease progression-related biomarkers. Antimicrob Agents Chemother. 2012;56:5858\u201364.","journal-title":"Antimicrob Agents Chemother"},{"key":"1617_CR9","doi-asserted-by":"publisher","first-page":"e1005540","DOI":"10.1371\/journal.ppat.1005540","volume":"12","author":"S Serrano-Villar","year":"2016","unstructured":"Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Wook-Chun T, Mann S, et al. Effects of combined CCR5\/integrase inhibitors-based regimen on mucosal immunity in HIV-infected patients na\u00efve to antiretroviral therapy: a pilot randomized trial. PLoS Pathog. 2016;12:e1005540.","journal-title":"PLoS Pathog"},{"key":"1617_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/cid\/civ455","volume":"61","author":"BO Taiwo","year":"2015","unstructured":"Taiwo BO, Chan ES, Fichtenbaum CJ, Ribaudo H, Tsibris A, Klingman KL, et al. Less bone loss with maraviroc-versus tenofovir-containing antiretroviral therapy in the AIDS Clinical Trials Group A5303 Study. Clin Infect Dis. 2015;61:1179\u201388.","journal-title":"Clin Infect Dis"},{"key":"1617_CR11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/infdis\/jiu180","volume":"210","author":"MM Pozo-Balado","year":"2014","unstructured":"Pozo-Balado MM, Mart\u00ednez-Bonet M, Rosado I, Ruiz-Mateos E, M\u00e9ndez- Lagares G, Rodr\u00edguez-M\u00e9ndez MM, et al. Maraviroc reduces the regulatory T-cell frequency in antiretroviral-naive HIV-infected subjects. J Infect Dis. 2014;210:890\u20138.","journal-title":"J Infect Dis"},{"key":"1617_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cmi.2015.12.025","volume":"22","author":"MM Pozo-Balado","year":"2016","unstructured":"Pozo-Balado MM, Rosado-S\u00e1nchez I, M\u00e9ndez-Lagares G, Rodr\u00edguez-M\u00e9ndez MM, Ruiz-Mateos E, Benhnia MR, et al. Maraviroc contributes to the restoration of the homeostasis of regulatory T-cell subsets in antiretroviral-naive HIV-infected subjects. Clin Microbiol Infect. 2016;22:461.","journal-title":"Clin Microbiol Infect."},{"key":"1617_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1086\/653707","volume":"202","author":"MM Pozo-Balado","year":"2010","unstructured":"Pozo-Balado MM, Leal M, M\u00e9ndez Lagares G, Mata RC, L\u00f3pez-Cort\u00e9s LF, Viciana P, et al. Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine. J Infect Dis. 2010;202:362\u20139.","journal-title":"J Infect Dis"},{"key":"1617_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1084\/jem.173.3.531","volume":"173","author":"E Egea","year":"1991","unstructured":"Egea E, Iglesias A, Salazar M, Morimoto C, Kruskall MS, Awdeh Z, et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med. 1991;173:531\u20138.","journal-title":"J Exp Med"},{"key":"1617_CR15","first-page":"405","volume":"71","author":"LG Filion","year":"1988","unstructured":"Filion LG, Saginur R, Szczerbak N. Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination. J Exp Immunol. 1988;71:405\u20139.","journal-title":"J Exp Immunol."},{"key":"1617_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00005-013-0219-0","volume":"61","author":"ZQ Yao","year":"2013","unstructured":"Yao ZQ, Moorman JP. Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and\/or HIV infection. Arch Immunol Ther Exp. 2013;61:193\u2013201.","journal-title":"Arch Immunol Ther Exp."},{"key":"1617_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4049\/jimmunol.181.2.1573","volume":"181","author":"N Vrisekoop","year":"2008","unstructured":"Vrisekoop N, van Gent R, de Boer AB, Otto SA, Borleffs JC, Steingrover R, et al. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging. J Immunol. 2008;181:1573\u201381.","journal-title":"J Immunol."},{"key":"1617_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1086\/433180","volume":"41","author":"ET Overton","year":"2005","unstructured":"Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK, Aberg JA. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis. 2005;41:1045\u20138.","journal-title":"Clin Infect Dis"},{"key":"1617_CR19","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/infdis\/jit006","volume":"207","author":"E Leeansyah","year":"2013","unstructured":"Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Velayudham P, Gouillou M, et al. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging. J Infect Dis. 2013;207:1157\u201365.","journal-title":"J Infect Dis"},{"issue":"8","key":"1617_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/infdis\/jiv202","volume":"212","author":"K Najarro","year":"2015","unstructured":"Najarro K, Nguyen H, Chen G, Xu M, Alcorta S, Yao X, et al. Telomere length as an indicator of the robustness of B- and T-cell response to influenza in older adults. J Infect Dis. 2015;212(8):1261\u20139.","journal-title":"J Infect Dis"},{"issue":"1","key":"1617_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12967-017-1367-5","volume":"15","author":"A Gonzalez-Serna","year":"2017","unstructured":"Gonzalez-Serna A, Ferrando-Martinez S, Tarancon-Diez L, De Pablo-Bernal RS, Dominguez-Molina B, Jim\u00e9nez JL, et al. Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens. J Transl Med. 2017;15(1):259.","journal-title":"J Transl Med."},{"issue":"8","key":"1617_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1089\/vim.2016.0046","volume":"29","author":"I Pulido","year":"2016","unstructured":"Pulido I, Genebat M, Alvarez-Rios AI, De Pablo-Bernal RS, Rafii-El-Idrissi Benhnia M, Pacheco YM, et al. Immunovirological efficacy of once-daily maraviroc plus ritonavir-boosted atazanavir After 48 weeks in naive HIV-infected patients. Viral Immunol. 2016;29(8):471\u20137.","journal-title":"Viral Immunol"},{"key":"1617_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1054-139X(01)00278-6","volume":"29","author":"CM Wilson","year":"2001","unstructured":"Wilson CM, Ellenberg JH, Sawyer MK, Belzer M, Crowley-Nowick PA, Puga A, et al. Adolescent Medicine HIV\/AIDS Research Network. Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for excellence in adolescent care and health. J Adolesc Health. 2001;29:123\u20139.","journal-title":"J Adolesc Health"},{"key":"1617_CR24","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1016\/j.vaccine.2011.02.092","volume":"29","author":"DD Anthony","year":"2011","unstructured":"Anthony DD, Umbleja T, Aberg JA, Kang M, Medvik K, Lederman MM, et al. Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals. Vaccine. 2011;29:3558\u201363.","journal-title":"Vaccine"},{"key":"1617_CR25","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1016\/j.vaccine.2006.06.079","volume":"4","author":"AP Veiga","year":"2006","unstructured":"Veiga AP, Casseb J, Duarte AJ. Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naive) and CD45RO+ (memory) subsets in HIV-1-infected subjects. Vaccine. 2006;4:7124\u20138.","journal-title":"Vaccine"},{"issue":"4","key":"1617_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.vaccine.2015.11.069","volume":"34","author":"M Jing","year":"2016","unstructured":"Jing M, Wang J, Zhu S, Ao F, Wang L, Han T, et al. Development of a more efficient hepatitis B virus\u00a0vaccine\u00a0by targeting hepatitis B virus preS to\u00a0dendritic cells. Vaccine. 2016;34(4):516\u201322.","journal-title":"Vaccine"},{"issue":"10","key":"1617_CR27","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1128\/JVI.00017-14","volume":"88","author":"W Jiang","year":"2014","unstructured":"Jiang W, Younes SA, Funderburg NT, Mudd JC, Espinosa E, Davenport MP, et al. Cycling memory CD4+\u2009T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation. J Virol. 2014;88(10):5369\u201380.","journal-title":"J Virol"},{"issue":"12","key":"1617_CR28","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.4049\/jimmunol.1201235","volume":"189","author":"D Sauce","year":"2012","unstructured":"Sauce D, Larsen M, Fastenackels S, Roux A, Gorochov G, Katlama C, et al. Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults. J Immunol. 2012;189(12):5541\u20138.","journal-title":"J Immunol."},{"key":"1617_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1182\/blood-2008-02-139154","volume":"113","author":"S Kohler","year":"2009","unstructured":"Kohler S, Thiel A. Life after the thymus: CD31+\u2009and CD31\u2212 human na\u00efve CD4+\u2009T-cell subsets. Blood. 2009;113:769\u201374.","journal-title":"Blood"},{"issue":"23","key":"1617_CR30","doi-asserted-by":"publisher","first-page":"13082","DOI":"10.1128\/JVI.78.23.13082-13089.2004","volume":"78","author":"FN Toka","year":"2004","unstructured":"Toka FN, Suvas S, Rouse BT. CD4+\u00a0CD25+\u00a0T\u00a0cells\u00a0regulate\u00a0vaccine-generated\u00a0primary\u00a0and\u00a0memory\u00a0CD8+\u00a0T-cell\u00a0responses against herpes simplex virus type 1. J Virol. 2004;78(23):13082\u20139.","journal-title":"J Virol"},{"issue":"8","key":"1617_CR31","doi-asserted-by":"publisher","first-page":"e104627","DOI":"10.1371\/journal.pone.0104627","volume":"9","author":"MR Espinoza-Mora","year":"2014","unstructured":"Espinoza-Mora MR, Steeg C, Tartz S, Heussler V, Sparwasser T, Link A, et al. Depletion of regulatory T cells augments a vaccine-induced T effector cell response against the liver-stage of malaria but fails to increase memory. PLoS ONE. 2014;9(8):e104627.","journal-title":"PLoS ONE"},{"key":"1617_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0004-9","author":"PH Lin","year":"2018","unstructured":"Lin PH, Wong WI, Wang YL, Hsieh MP, Lu CW, Liang CY, et al. Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection. Mucosal Immunol. 2018. \n                    https:\/\/doi.org\/10.1038\/s41385-018-0004-9\n                    \n                  .","journal-title":"Mucosal Immunol"},{"key":"1617_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","volume":"13","author":"M Miyara","year":"2007","unstructured":"Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med. 2007;13:108\u201316.","journal-title":"Trends Mol Med."},{"key":"1617_CR34","doi-asserted-by":"publisher","first-page":"19446","DOI":"10.1073\/pnas.0706832104","volume":"104","author":"MM Tiemessen","year":"2007","unstructured":"Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. CD4+CD25+Foxp3+regulatory T cells induce alternative activation of human monocytes\/macrophages. Proc Natl Acad Sci USA. 2007;104:19446\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1617_CR35","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","volume":"175","author":"HW Lim","year":"2005","unstructured":"Lim HW, Hillsamer P, Banham AH. KimCH.\u00a0Cutting edge: direct suppression of B cells by CD4+CD25+\u2009regulatory T cells. J Immunol. 2005;175:4180\u20133.","journal-title":"J Immunol."},{"issue":"4","key":"1617_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.vaccine.2017.12.018","volume":"36","author":"CL Shive","year":"2018","unstructured":"Shive CL, Judge CJ, Clagett B, Kalayjian RC, Osborn M, Sherman KE, et al. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine. 2018;36(4):453\u201360.","journal-title":"Vaccine"},{"issue":"2","key":"1617_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/infdis\/jix257","volume":"216","author":"CP Verschoor","year":"2017","unstructured":"Verschoor CP, Lelic A, Parsons R, Evelegh C, Bramson JL, Johnstone J, et al. Serum C-reactive protein and congestive heart failure as significant predictors of herpes zoster vaccine response in elderly nursing home residents. J Infect Dis. 2017;216(2):191\u20137.","journal-title":"J Infect Dis."},{"key":"1617_CR38","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1086\/344271","volume":"35","author":"DN Fisman","year":"2002","unstructured":"Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35:1368\u201375.","journal-title":"Clin Infect Dis"},{"key":"1617_CR39","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.vaccine.2016.02.055","volume":"34","author":"F Fuster","year":"2016","unstructured":"Fuster F, Vargas JI, Jensen D, Sarmiento V, Acu\u00f1a P, Peirano F, et al. CD4\/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: a prospective cohort study. Vaccine. 2016;34:1889\u201395.","journal-title":"Vaccine"},{"key":"1617_CR40","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/cid\/ciw076","volume":"62","author":"F Caby","year":"2016","unstructured":"Caby F, Guihot A, Lambert-Niclot S, Guiguet M, Boutolleau D, Agher R, et al. Determinants of a low CD4\/CD ratio in HIV-1 infected individuals despite long term viral suppression. Clin Infect Dis. 2016;62:1297\u2013303.","journal-title":"Clin Infect Dis"},{"key":"1617_CR41","first-page":"127","volume":"17","author":"S Nozza","year":"2015","unstructured":"Nozza S, Svicher V, Saracino A, d\u2019Ettorre G, De Luca A, Maggiolo F, et al. State of the art of dual therapy in 2015. AIDS Rev. 2015;17:127\u201334.","journal-title":"AIDS Rev."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1617-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T21:37:40Z","timestamp":1569188260000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1617-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1617-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/298521","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"23 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"238"}}